Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
4.203
-0.067 (-1.56%)
May 14, 2025, 10:24 AM - Market open
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Recurring - Non-capital | 11.29M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Recurring - Non-capital Growth | 22.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Capital Equipment | 3.34M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Capital Equipment Growth | 530.19% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Magnetic Resonance Guided Ablation Procedures | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Magnetic Resonance Guided Ablation Procedures Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Service | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Service Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pay per Procedure | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| United States | 10.07M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 45.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Canada | 3.34M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Canada Growth | 976.36% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Germany | 1.22M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Germany Growth | -50.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|